Skip to main content
Top
Published in: Insights into Imaging 1/2021

01-12-2021 | Metastasis | Educational Review

Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting

Authors: Federica Vernuccio, Domenico Salvatore Gagliano, Roberto Cannella, Ahmed Ba-Ssalamah, An Tang, Giuseppe Brancatelli

Published in: Insights into Imaging | Issue 1/2021

Login to get access

Abstract

Hepatobiliary MRI contrast agents are increasingly being used for liver imaging. In clinical practice, most focal liver lesions do not uptake hepatobiliary contrast agents. Less commonly, hepatic lesions may show variable signal characteristics on hepatobiliary phase. This pictorial essay reviews a broad spectrum of benign and malignant focal hepatic observations that may show hyperintensity on hepatobiliary phase in various clinical settings. In non-cirrhotic patients, focal hepatic observations that show hyperintensity in the hepatobiliary phase are usually benign and typically include focal nodular hyperplasia. In patients with primary or secondary vascular disorders, focal nodular hyperplasia-like lesions arise as a local hyperplastic response to vascular alterations and tend to be iso- or hyperintense in the hepatobiliary phase. In oncologic patients, metastases and cholangiocarcinoma are hypointense lesions in the hepatobiliary phase; however, occasionally they may show a diffuse, central and inhomogeneous hepatobiliary paradoxical uptake with peripheral rim hypointensity. Post-chemotherapy focal nodular hyperplasia-like lesions may be tricky, and their typical hyperintense rim in the hepatobiliary phase is very helpful for the differential diagnosis with metastases. In cirrhotic patients, hepatocellular carcinoma may occasionally appear hyperintense on hepatobiliary phase.
Literature
1.
go back to reference Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429PubMedCrossRef Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429PubMedCrossRef
2.
go back to reference Dahlqvist Leinhard O, Dahlström N, Kihlberg J et al (2012) Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. Eur Radiol 22:642–653PubMedCrossRef Dahlqvist Leinhard O, Dahlström N, Kihlberg J et al (2012) Quantifying differences in hepatic uptake of the liver specific contrast agents Gd-EOB-DTPA and Gd-BOPTA: a pilot study. Eur Radiol 22:642–653PubMedCrossRef
3.
go back to reference Spinazzi A, Lorusso V, Pirovano G, Kirchin M (1999) Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 6(5):282–291PubMedCrossRef Spinazzi A, Lorusso V, Pirovano G, Kirchin M (1999) Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 6(5):282–291PubMedCrossRef
4.
go back to reference Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N (2009) Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers. Acta Radiol 50:709–715PubMedCrossRef Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N (2009) Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers. Acta Radiol 50:709–715PubMedCrossRef
5.
go back to reference Feuerlein S, Gupta RT, Boll DT, Merkle EM (2012) Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine. Eur J Radiol 81:2037–2041PubMedCrossRef Feuerlein S, Gupta RT, Boll DT, Merkle EM (2012) Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine. Eur J Radiol 81:2037–2041PubMedCrossRef
6.
go back to reference Vernuccio F, Cannella R, Gozzo C et al (2020) Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine? Abdom Radiol (NY) 45(8):2409–2417CrossRef Vernuccio F, Cannella R, Gozzo C et al (2020) Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine? Abdom Radiol (NY) 45(8):2409–2417CrossRef
7.
go back to reference Yoneda N, Matsui O, Kitao A et al (2016) Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background. Radiographics 36:2010–2027PubMedCrossRef Yoneda N, Matsui O, Kitao A et al (2016) Benign hepatocellular nodules: hepatobiliary phase of gadoxetic acid-enhanced MR imaging based on molecular background. Radiographics 36:2010–2027PubMedCrossRef
9.
go back to reference Hansen N, Weadock W, Morani A et al (2012) Liver lesions discovered incidentally on ultrasound: evaluation of reader ability to characterize lesions on MRI without intravenous contrast. Acad Radiol 19:1087–1093PubMedCrossRef Hansen N, Weadock W, Morani A et al (2012) Liver lesions discovered incidentally on ultrasound: evaluation of reader ability to characterize lesions on MRI without intravenous contrast. Acad Radiol 19:1087–1093PubMedCrossRef
10.
go back to reference Suh CH, Kim KW, Kim GY, Shin YM, Kim PN, Park SH (2015) The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Eur Radiol 25:950–960PubMedCrossRef Suh CH, Kim KW, Kim GY, Shin YM, Kim PN, Park SH (2015) The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Eur Radiol 25:950–960PubMedCrossRef
11.
go back to reference McInnes MD, Hibbert RM, Inácio JR, Schieda N (2015) Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid-enhanced MR imaging—a systematic review. Radiology 277:413–423PubMedCrossRef McInnes MD, Hibbert RM, Inácio JR, Schieda N (2015) Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid-enhanced MR imaging—a systematic review. Radiology 277:413–423PubMedCrossRef
12.
go back to reference Reddy SK, Kishnani PS, Sullivan JA et al (2007) Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 47:658–663PubMedCrossRef Reddy SK, Kishnani PS, Sullivan JA et al (2007) Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 47:658–663PubMedCrossRef
13.
go back to reference Thomeer MG, Willemssen FE, Biermann KK et al (2014) MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. J Magn Reson Imaging 39:1259–1264PubMedCrossRef Thomeer MG, Willemssen FE, Biermann KK et al (2014) MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. J Magn Reson Imaging 39:1259–1264PubMedCrossRef
14.
go back to reference Glockner JF, Lee CU (2017) Mounajjed T inflammatory hepatic adenomas: characterization with hepatobiliary MRI contrast agents. Magn Reson Imaging. 47:103–110PubMedCrossRef Glockner JF, Lee CU (2017) Mounajjed T inflammatory hepatic adenomas: characterization with hepatobiliary MRI contrast agents. Magn Reson Imaging. 47:103–110PubMedCrossRef
16.
go back to reference Denecke T, Steffen IG, Agarwal S et al (2012) Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol 22(8):1769–1775PubMedCrossRef Denecke T, Steffen IG, Agarwal S et al (2012) Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol 22(8):1769–1775PubMedCrossRef
17.
go back to reference Ünal E, İdilman İS, Karaosmanoğlu AD et al (2019) Hyperintensity at fat spared area in steatotic liver on the hepatobiliary phase MRI. Diagn Interv Radiol 25:416–420PubMedPubMedCentralCrossRef Ünal E, İdilman İS, Karaosmanoğlu AD et al (2019) Hyperintensity at fat spared area in steatotic liver on the hepatobiliary phase MRI. Diagn Interv Radiol 25:416–420PubMedPubMedCentralCrossRef
18.
go back to reference Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201:W603–W611PubMedCrossRef Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201:W603–W611PubMedCrossRef
19.
go back to reference Koh J, Chung YE, Nahm JH et al (2016) Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol 26:407–416PubMedCrossRef Koh J, Chung YE, Nahm JH et al (2016) Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI. Eur Radiol 26:407–416PubMedCrossRef
20.
go back to reference Min JH, Kim YK, Choi SY et al (2017) Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum. Eur J Radiol 92:1–10PubMedCrossRef Min JH, Kim YK, Choi SY et al (2017) Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum. Eur J Radiol 92:1–10PubMedCrossRef
21.
go back to reference Park HJ, Kim YK, Park MJ, Lee WJ (2013) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 38:793–801PubMedCrossRef Park HJ, Kim YK, Park MJ, Lee WJ (2013) Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 38:793–801PubMedCrossRef
22.
go back to reference Ha S, Lee CH, Kim BH et al (2012) Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the “target sign” a common finding? Magn Reson Imaging 30:1083–1090PubMedCrossRef Ha S, Lee CH, Kim BH et al (2012) Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the “target sign” a common finding? Magn Reson Imaging 30:1083–1090PubMedCrossRef
23.
go back to reference Kim A, Lee CH, Kim BH et al (2012) Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a “defect” on the hepatobiliary phase. Eur J Radiol 81:3998–4004PubMedCrossRef Kim A, Lee CH, Kim BH et al (2012) Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a “defect” on the hepatobiliary phase. Eur J Radiol 81:3998–4004PubMedCrossRef
24.
go back to reference Nguyen BN, Fléjou JF, Terris B et al (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441–1454PubMedCrossRef Nguyen BN, Fléjou JF, Terris B et al (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441–1454PubMedCrossRef
25.
go back to reference Kaltenbach TE, Engler P, Kratzer W et al (2016) Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol (NY) 41:25–32CrossRef Kaltenbach TE, Engler P, Kratzer W et al (2016) Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol (NY) 41:25–32CrossRef
26.
go back to reference International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993CrossRef International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993CrossRef
27.
go back to reference European Association for the Study of the Liver (EASL) (2016) EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol 65:386–398CrossRef European Association for the Study of the Liver (EASL) (2016) EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol 65:386–398CrossRef
28.
go back to reference Vernuccio F, Ronot M, Dioguardi Burgio M et al (2018) Uncommon evolutions and complications of common benign liver lesions. Abdom Radiol (NY) 43:2075–2096CrossRef Vernuccio F, Ronot M, Dioguardi Burgio M et al (2018) Uncommon evolutions and complications of common benign liver lesions. Abdom Radiol (NY) 43:2075–2096CrossRef
29.
go back to reference Yoneda N, Matsui O, Kitao A et al (2012) Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol 30:499–508PubMedCrossRef Yoneda N, Matsui O, Kitao A et al (2012) Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol 30:499–508PubMedCrossRef
30.
go back to reference Fujiwara H, Sekine S, Onaya H et al (2011) Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation. Jpn J Radiol 29:739–743PubMedCrossRef Fujiwara H, Sekine S, Onaya H et al (2011) Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation. Jpn J Radiol 29:739–743PubMedCrossRef
31.
go back to reference Bioulac-Sage P, Cubel G, Taouji S et al (2012) Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol 36:1691–1699PubMedCrossRef Bioulac-Sage P, Cubel G, Taouji S et al (2012) Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol 36:1691–1699PubMedCrossRef
32.
go back to reference Reizine E, Amaddeo G, Pigneur F et al (2018) Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Eur Radiol 28:4243–4253PubMedCrossRef Reizine E, Amaddeo G, Pigneur F et al (2018) Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Eur Radiol 28:4243–4253PubMedCrossRef
33.
go back to reference van Kessel CS, de Boer E, ten Kate FJ, Brosens LA, Veldhuis WB, van Leeuwen MS (2013) Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI. Abdom Imaging 38:490–501PubMedCrossRef van Kessel CS, de Boer E, ten Kate FJ, Brosens LA, Veldhuis WB, van Leeuwen MS (2013) Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI. Abdom Imaging 38:490–501PubMedCrossRef
34.
go back to reference Bieze M, van den Esschert JW, Nio CY et al (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 199:26–34PubMedCrossRef Bieze M, van den Esschert JW, Nio CY et al (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 199:26–34PubMedCrossRef
35.
go back to reference Grieser C, Steffen IG, Kramme IB et al (2014) Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 24(6):1339–1348PubMedCrossRef Grieser C, Steffen IG, Kramme IB et al (2014) Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Eur Radiol 24(6):1339–1348PubMedCrossRef
36.
go back to reference An HS, Park HS, Kim YJ, Jung SI, Jeon HJ (2013) Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI. Br J Radiol 86:20130299PubMedPubMedCentralCrossRef An HS, Park HS, Kim YJ, Jung SI, Jeon HJ (2013) Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI. Br J Radiol 86:20130299PubMedPubMedCentralCrossRef
37.
go back to reference Mohajer K, Frydrychowicz A, Robbins JB, Loeffler AG, Reed TD, Reeder SB (2012) Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging 36:686–696PubMedPubMedCentralCrossRef Mohajer K, Frydrychowicz A, Robbins JB, Loeffler AG, Reed TD, Reeder SB (2012) Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. J Magn Reson Imaging 36:686–696PubMedPubMedCentralCrossRef
38.
go back to reference Kitao A, Matsui O, Yoneda N et al (2018) Differentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of gadoxetic acid-enhanced MRI and focal nodular hyperplasia by CT and MRI. AJR Am J Roentgenol 211(2):347–357PubMedCrossRef Kitao A, Matsui O, Yoneda N et al (2018) Differentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of gadoxetic acid-enhanced MRI and focal nodular hyperplasia by CT and MRI. AJR Am J Roentgenol 211(2):347–357PubMedCrossRef
39.
go back to reference Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529PubMedCrossRef Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529PubMedCrossRef
40.
go back to reference Giovanoli O, Heim M, Terracciano L et al (2008) MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR Am J Roentgenol 190:W290–W293PubMedCrossRef Giovanoli O, Heim M, Terracciano L et al (2008) MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients. AJR Am J Roentgenol 190:W290–W293PubMedCrossRef
41.
go back to reference Gevers TJG, Marcel Spanier BW, Veendrick PB, Vrolijk JM (2018) Regression of hepatocellular adenoma after bariatric surgery in severe obese patients. Liver Int 38:2134–2136PubMedCrossRef Gevers TJG, Marcel Spanier BW, Veendrick PB, Vrolijk JM (2018) Regression of hepatocellular adenoma after bariatric surgery in severe obese patients. Liver Int 38:2134–2136PubMedCrossRef
42.
go back to reference Vernuccio F, Ronot M, Dioguardi Burgio M et al (2020) Long-term evolution of hepatocellular adenomas at MRI follow-up. Radiology 295:361–372PubMedCrossRef Vernuccio F, Ronot M, Dioguardi Burgio M et al (2020) Long-term evolution of hepatocellular adenomas at MRI follow-up. Radiology 295:361–372PubMedCrossRef
43.
go back to reference Nault JC, Couchy G, Balabaud C et al (2017) Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 152(880–894):e6 Nault JC, Couchy G, Balabaud C et al (2017) Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 152(880–894):e6
44.
go back to reference Ba-Ssalamah A, Antunes C, Feier D et al (2015) Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Radiology 277:104–113PubMedCrossRef Ba-Ssalamah A, Antunes C, Feier D et al (2015) Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Radiology 277:104–113PubMedCrossRef
45.
go back to reference Sciarra A, Schmidt S, Pellegrinelli A et al (2019) OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy. Liver Int 39:158–167PubMedCrossRef Sciarra A, Schmidt S, Pellegrinelli A et al (2019) OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy. Liver Int 39:158–167PubMedCrossRef
46.
go back to reference Yoneda N, Matsui O, Kitao A et al (2012b) Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol 30:777–782PubMedCrossRef Yoneda N, Matsui O, Kitao A et al (2012b) Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol 30:777–782PubMedCrossRef
47.
go back to reference Agarwal S, Fuentes-Orrego JM, Arnason T et al (2014) Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol 203:W408–W414PubMedCrossRef Agarwal S, Fuentes-Orrego JM, Arnason T et al (2014) Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol 203:W408–W414PubMedCrossRef
48.
go back to reference Dioguardi Burgio M, Bruno O, Agnello F et al (2016) The cheating liver: imaging of focal steatosis and fatty sparing. Expert Rev Gastroenterol Hepatol 10:671–678PubMedCrossRef Dioguardi Burgio M, Bruno O, Agnello F et al (2016) The cheating liver: imaging of focal steatosis and fatty sparing. Expert Rev Gastroenterol Hepatol 10:671–678PubMedCrossRef
49.
go back to reference Vilgrain V, Paradis V, Van Wettere M et al (2018) Benign and malignant hepatocellular lesions in patients with vascular liver diseases. Abdom Radiol (NY) 43:1968–1977CrossRef Vilgrain V, Paradis V, Van Wettere M et al (2018) Benign and malignant hepatocellular lesions in patients with vascular liver diseases. Abdom Radiol (NY) 43:1968–1977CrossRef
50.
go back to reference Marin D, Galluzzo A, Plessier A, Brancatelli G, Valla D, Vilgrain V (2011) Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Eur Radiol 21:2074–2082PubMedCrossRef Marin D, Galluzzo A, Plessier A, Brancatelli G, Valla D, Vilgrain V (2011) Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history. Eur Radiol 21:2074–2082PubMedCrossRef
51.
go back to reference Baiges A, Turon F, Simón-Talero M et al (2020) Congenital extrahepatic portosystemic shunts (abernethy malformation): an international observational study. Hepatology 71:658–669PubMedCrossRef Baiges A, Turon F, Simón-Talero M et al (2020) Congenital extrahepatic portosystemic shunts (abernethy malformation): an international observational study. Hepatology 71:658–669PubMedCrossRef
52.
go back to reference Brenard R, Chapaux X, Deltenre P et al (2010) Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients. Eur J Gastroenterol Hepatol 22:1253–1259PubMedCrossRef Brenard R, Chapaux X, Deltenre P et al (2010) Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients. Eur J Gastroenterol Hepatol 22:1253–1259PubMedCrossRef
53.
go back to reference Vilgrain V, Lewin M, Vons C et al (1999) Hepatic nodules in Budd–Chiari syndrome: imaging features. Radiology 210:443–450PubMedCrossRef Vilgrain V, Lewin M, Vons C et al (1999) Hepatic nodules in Budd–Chiari syndrome: imaging features. Radiology 210:443–450PubMedCrossRef
54.
go back to reference Lee YH, Kim SH, Cho MY, Shim KY, Kim MS (2007) Focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation. AJR Am J Roentgenol 188:459–463CrossRef Lee YH, Kim SH, Cho MY, Shim KY, Kim MS (2007) Focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation. AJR Am J Roentgenol 188:459–463CrossRef
55.
go back to reference Galia M, Taibbi A, Marin D et al (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20(3):222–228PubMedPubMedCentralCrossRef Galia M, Taibbi A, Marin D et al (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20(3):222–228PubMedPubMedCentralCrossRef
56.
go back to reference Furlan A, Brancatelli G, Dioguardi Burgio M et al (2018) Focal nodular hyperplasia after treatment with oxaliplatin: a multiinstitutional series of cases diagnosed at MRI. AJR Am J Roentgenol 210:775–779PubMedCrossRef Furlan A, Brancatelli G, Dioguardi Burgio M et al (2018) Focal nodular hyperplasia after treatment with oxaliplatin: a multiinstitutional series of cases diagnosed at MRI. AJR Am J Roentgenol 210:775–779PubMedCrossRef
57.
go back to reference Rubbia-Brandt L, Lauwers GY, Wang H et al (2010) Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56:430–439PubMedCrossRef Rubbia-Brandt L, Lauwers GY, Wang H et al (2010) Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56:430–439PubMedCrossRef
58.
go back to reference Yang HK, Jang HJ, Khalili K, Wald RM, Yoo SJ, Kim TK (2020) CT and MR imaging findings of the livers in adults with Fontan palliation: an observational study. Abdom Radiol (NY) 45:188–202CrossRef Yang HK, Jang HJ, Khalili K, Wald RM, Yoo SJ, Kim TK (2020) CT and MR imaging findings of the livers in adults with Fontan palliation: an observational study. Abdom Radiol (NY) 45:188–202CrossRef
59.
go back to reference Mamone G, Carollo V, Di Piazza A, Cortis K, Degiorgio S, Miraglia R (2019) Budd–Chiari syndrome and hepatic regenerative nodules: magnetic resonance findings with emphasis of hepatobiliary phase. Eur J Radiol 117:15–25PubMedCrossRef Mamone G, Carollo V, Di Piazza A, Cortis K, Degiorgio S, Miraglia R (2019) Budd–Chiari syndrome and hepatic regenerative nodules: magnetic resonance findings with emphasis of hepatobiliary phase. Eur J Radiol 117:15–25PubMedCrossRef
60.
go back to reference Bruneton JN, Raffaelli C, Maestro C et al (1995) Benign liver lesions: implications of detection in cancer patients. Eur Radiol 5:387–390CrossRef Bruneton JN, Raffaelli C, Maestro C et al (1995) Benign liver lesions: implications of detection in cancer patients. Eur Radiol 5:387–390CrossRef
61.
go back to reference Schwartz LH, Gandras EJ, Colangelo S et al (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210:71–74PubMedCrossRef Schwartz LH, Gandras EJ, Colangelo S et al (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210:71–74PubMedCrossRef
62.
go back to reference Jones EC, Chezmar JL, Nelson RC, Bernardino ME (1992) The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol 158:535–539PubMedCrossRef Jones EC, Chezmar JL, Nelson RC, Bernardino ME (1992) The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol 158:535–539PubMedCrossRef
63.
go back to reference Jang HJ, Lim HK, Lee WJ, Lee SJ, Yun JY, Choi D (2002) Small hypoattenuating lesions in the liver on single-phase helical CT in preoperative patients with gastric and colorectal cancer: prevalence, significance, and differentiating features. J Comput Assist Tomogr 26:718–724PubMedCrossRef Jang HJ, Lim HK, Lee WJ, Lee SJ, Yun JY, Choi D (2002) Small hypoattenuating lesions in the liver on single-phase helical CT in preoperative patients with gastric and colorectal cancer: prevalence, significance, and differentiating features. J Comput Assist Tomogr 26:718–724PubMedCrossRef
64.
go back to reference Expert Panel on Gastrointestinal Imaging (2017) ACR Appropriateness Criteria® suspected liver metastases. J Am Coll Radiol 14:S314–S325CrossRef Expert Panel on Gastrointestinal Imaging (2017) ACR Appropriateness Criteria® suspected liver metastases. J Am Coll Radiol 14:S314–S325CrossRef
65.
go back to reference de Ridder J, de Wilt JH, Simmer F et al (2016) Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget 7:55368–55376PubMedPubMedCentralCrossRef de Ridder J, de Wilt JH, Simmer F et al (2016) Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget 7:55368–55376PubMedPubMedCentralCrossRef
66.
go back to reference Jeong HT, Kim MJ, Park MS et al (2012) Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging. J Magn Reson Imaging 35:635–643PubMedCrossRef Jeong HT, Kim MJ, Park MS et al (2012) Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging. J Magn Reson Imaging 35:635–643PubMedCrossRef
67.
go back to reference Granata V, Fusco R, de Lutio di Castelguidone E et al (2019) Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection. BMC Gastroenterol 19:129PubMedPubMedCentralCrossRef Granata V, Fusco R, de Lutio di Castelguidone E et al (2019) Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection. BMC Gastroenterol 19:129PubMedPubMedCentralCrossRef
68.
go back to reference Kim YK, Lee MW, Lee WJ et al (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter). Invest Radiol 47(3):159–166PubMedCrossRef Kim YK, Lee MW, Lee WJ et al (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter). Invest Radiol 47(3):159–166PubMedCrossRef
69.
go back to reference Park SH, Kim H, Kim EK et al (2017) Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI. Oncotarget 8:71012–71023PubMedPubMedCentralCrossRef Park SH, Kim H, Kim EK et al (2017) Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI. Oncotarget 8:71012–71023PubMedPubMedCentralCrossRef
70.
go back to reference Wlcek K, Svoboda M, Riha J et al (2011) The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer. Cancer Biol Ther 11:801–811PubMedCrossRef Wlcek K, Svoboda M, Riha J et al (2011) The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer. Cancer Biol Ther 11:801–811PubMedCrossRef
71.
go back to reference Mahfouz AE, Hamm B, Wolf KJ (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 190:49–52PubMedCrossRef Mahfouz AE, Hamm B, Wolf KJ (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 190:49–52PubMedCrossRef
72.
74.
go back to reference Jeon TY, Kim SH, Lee WJ et al (2010) The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging 35:337–345PubMedCrossRef Jeon TY, Kim SH, Lee WJ et al (2010) The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging 35:337–345PubMedCrossRef
75.
go back to reference Vernuccio F, Cannella R, Meyer M et al (2019) LI-RADS: diagnostic performance of hepatobiliary phase hypointensity and major imaging features of LR-3 and LR-4 lesions measuring 10–19 mm with arterial phase hyperenhancement. AJR Am J Roentgenol 213:W57–W65PubMedCrossRef Vernuccio F, Cannella R, Meyer M et al (2019) LI-RADS: diagnostic performance of hepatobiliary phase hypointensity and major imaging features of LR-3 and LR-4 lesions measuring 10–19 mm with arterial phase hyperenhancement. AJR Am J Roentgenol 213:W57–W65PubMedCrossRef
76.
go back to reference Kitao A, Matsui O, Yoneda N et al (2011) The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 21:2056–2066PubMedCrossRef Kitao A, Matsui O, Yoneda N et al (2011) The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 21:2056–2066PubMedCrossRef
77.
go back to reference Liu X, Zou L, Liu F, Zhou Y, Song B (2013) Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. PLoS ONE 8:e70896PubMedPubMedCentralCrossRef Liu X, Zou L, Liu F, Zhou Y, Song B (2013) Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis. PLoS ONE 8:e70896PubMedPubMedCentralCrossRef
79.
go back to reference Kim JY, Kim MJ, Kim KA, Jeong HT, Park YN (2012) Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Eur J Radiol 81:3877–3882PubMedCrossRef Kim JY, Kim MJ, Kim KA, Jeong HT, Park YN (2012) Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features. Eur J Radiol 81:3877–3882PubMedCrossRef
80.
go back to reference Asayama Y, Tajima T, Nishie A et al (2011) Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production. Eur J Radiol 80:e243-1248PubMedCrossRef Asayama Y, Tajima T, Nishie A et al (2011) Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production. Eur J Radiol 80:e243-1248PubMedCrossRef
81.
go back to reference Cannella R, Calandra A, Cabibbo G et al (2019) Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: outcome and rate of hypervascular transformation. Eur J Radiol 120:108689PubMedCrossRef Cannella R, Calandra A, Cabibbo G et al (2019) Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: outcome and rate of hypervascular transformation. Eur J Radiol 120:108689PubMedCrossRef
82.
go back to reference Yamashita T, Kitao A, Matsui O et al (2014) Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology 60:1674–1685PubMedCrossRef Yamashita T, Kitao A, Matsui O et al (2014) Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology 60:1674–1685PubMedCrossRef
83.
go back to reference Narita M, Hatano E, Arizono S et al (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793–798PubMedCrossRef Narita M, Hatano E, Arizono S et al (2009) Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 44:793–798PubMedCrossRef
85.
go back to reference Tsuboyama T, Onishi H, Kim T et al (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging—correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824–833PubMedCrossRef Tsuboyama T, Onishi H, Kim T et al (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging—correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255:824–833PubMedCrossRef
86.
go back to reference Ueno A, Masugi Y, Yamazaki K et al (2014) OATP1B3 expression is strongly associated with Wnt/beta-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. J Hepatol 61:1080–1087PubMedCrossRef Ueno A, Masugi Y, Yamazaki K et al (2014) OATP1B3 expression is strongly associated with Wnt/beta-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. J Hepatol 61:1080–1087PubMedCrossRef
87.
go back to reference Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging—correlation with molecular transporters and histopathologic features. Radiology 256:817–826PubMedCrossRef Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging—correlation with molecular transporters and histopathologic features. Radiology 256:817–826PubMedCrossRef
88.
go back to reference Yoneda N, Matsui O, Kitao A et al (2018) Peri-tumoral hyperintensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in hepatocellular carcinomas: correlation with peri-tumoral hyperplasia and its pathological features. Abdom Radiol (NY) 43:2103–2112CrossRef Yoneda N, Matsui O, Kitao A et al (2018) Peri-tumoral hyperintensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in hepatocellular carcinomas: correlation with peri-tumoral hyperplasia and its pathological features. Abdom Radiol (NY) 43:2103–2112CrossRef
89.
go back to reference Theise ND (1996) Cirrhosis and hepatocellular neoplasia: more like cousins than like parent and child. Gastroenterology 111:526–528PubMedCrossRef Theise ND (1996) Cirrhosis and hepatocellular neoplasia: more like cousins than like parent and child. Gastroenterology 111:526–528PubMedCrossRef
90.
go back to reference Kozaka K, Kobayashi S, Yoneda N et al (2019) Doughnut-like hyperintense nodules in the hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features. Eur Radiol 29:6489–6498PubMedCrossRef Kozaka K, Kobayashi S, Yoneda N et al (2019) Doughnut-like hyperintense nodules in the hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features. Eur Radiol 29:6489–6498PubMedCrossRef
91.
go back to reference Kobayashi S, Matsui O, Gabata T et al (2013) Intrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI: imaging findings and prevalence in various hepatobiliary diseases. Jpn J Radiol 31:9–15PubMedCrossRef Kobayashi S, Matsui O, Gabata T et al (2013) Intrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI: imaging findings and prevalence in various hepatobiliary diseases. Jpn J Radiol 31:9–15PubMedCrossRef
92.
go back to reference Onishi H, Theisen D, Zachoval R, Reiser MF, Zech CJ (2019) Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: do they correspond to periportal hyperintense patterns on T2-weighted images? Medicine (Baltimore) 98:e14784CrossRef Onishi H, Theisen D, Zachoval R, Reiser MF, Zech CJ (2019) Intrahepatic diffuse periportal enhancement patterns on hepatobiliary phase gadoxetate disodium-enhanced liver MR images: do they correspond to periportal hyperintense patterns on T2-weighted images? Medicine (Baltimore) 98:e14784CrossRef
93.
go back to reference Vernuccio F, Dioguardi Burgio M, Barbiera F et al (2019) CT and MR imaging of chemotherapy-induced hepatopathy. Abdom Radiol (NY) 44(10):3312–3324CrossRef Vernuccio F, Dioguardi Burgio M, Barbiera F et al (2019) CT and MR imaging of chemotherapy-induced hepatopathy. Abdom Radiol (NY) 44(10):3312–3324CrossRef
Metadata
Title
Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting
Authors
Federica Vernuccio
Domenico Salvatore Gagliano
Roberto Cannella
Ahmed Ba-Ssalamah
An Tang
Giuseppe Brancatelli
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 1/2021
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-020-00928-w

Other articles of this Issue 1/2021

Insights into Imaging 1/2021 Go to the issue